| A Phase I, First-in-Human Study of GB268 (PD-1/CTLA-4/VEGF Trispecific Antibody) in Advanced Solid Tumors (NCT06934616) | Genor Biopharma Co., Ltd. | 2025-04-24 |
| A Study of [14C]GB491 in Male Healthy Subjects (NCT05860582) | Genor Biopharma Co., Ltd. | 2022-09-14 |
| A Safety, Tolerability, PK and Preliminary Activity Study of GB263T in Advanced NSCLC and Other Solid Tumor (NCT05332574) | Genor Biopharma Co., Ltd. | 2022-05-17 |
| A Study of GB491 in Combination With Letrozole in Patients With HR Positive and HER2 Negative Advanced Breast Cancer (NCT05851014) | Genor Biopharma Co., Ltd. | 2022-01-14 |
| GB491 Combined With Fulvestrant for HR+ HER2- Locally Advanced or Metastatic Breast Cancer (NCT05054751) | Genor Biopharma Co., Ltd. | 2021-09-10 |
| A Safety, Tolerability, Pharmacokinetics and Efficacy Study of GB261 in B-Cell NHL and CLL. (NCT04923048) | Genor Biopharma Co., Ltd. | 2021-08-31 |
| A Phase Ib Study of GB491 Plus Letrozole in Patients With Advanced Breast Cancer (NCT05337657) | Genor Biopharma Co., Ltd. | 2021-06-02 |
| Single Dose Pharmacokinetic Study of GB221 in Comparison With Herceptin ® (NCT04905667) | Genor Biopharma Co., Ltd. | 2019-11-13 |
| A Study to Evaluate the Safety and Tolerability of Multiple Doses of Gerilimzumab in Rheumatoid Arthritis Patients (NCT04179513) | Genor Biopharma Co., Ltd. | 2019-08-15 |
| A Study in Recurrent or Metastatic Cervical Cancer Patients With PD-L1 Positive (NCT03808857) | Genor Biopharma Co., Ltd. | 2019-05-23 |
| Geptanolimab(GB226) Combined With Fruquintinib in the Treatment of Metastatic Colorectal Cancer (NCT03977090) | Genor Biopharma Co., Ltd. | 2019-04-04 |
| Phase Ⅰ Clinical Study Protocol of GB223 Monoclonal Antibody Injection (NCT04178044) | Genor Biopharma Co., Ltd. | 2018-11-16 |
| Clinical Trial in Chinese Patients of B-cell Non-Hodgkin's Lymphoma(GB226) (NCT03639181) | Genor Biopharma Co., Ltd. | 2018-10-15 |
| Clinical Trial in Chinese Patients of Elapsed/Metastatic/Unresectable Alveolar Soft Part Sarcoma(GB226) (NCT03623581) | Genor Biopharma Co., Ltd. | 2018-09-06 |
| Clinical Trial in Chinese Patients of Relapsed and Refractory Peripheral T Cell Lymphoma (GB226) (NCT03502629) | Genor Biopharma Co., Ltd. | 2018-07-02 |
| Phase Ⅰ Clinical Trial of Gerilimzumab Injection in Healthy Subjects (NCT04178070) | Genor Biopharma Co., Ltd. | 2017-11-06 |
| Phase I Clinical Trial in Chinese Patients of Advanced and (or) Recurrent Solid Tumor/Lymphoma (NCT03374007) | Genor Biopharma Co., Ltd. | 2017-10-19 |
| Clinical Comparative Study to Evaluate the Efficacy and Safety of Recombinant Anti-TNF-alpha Antibodies for Injection (NCT04178850) | Genor Biopharma Co., Ltd. | 2017-10-13 |